Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 3739

1.

ST-segment recovery and outcome after primary percutaneous coronary intervention for ST-elevation myocardial infarction: insights from the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) trial.

Buller CE, Fu Y, Mahaffey KW, Todaro TG, Adams P, Westerhout CM, White HD, van 't Hof AW, Van de Werf FJ, Wagner GS, Granger CB, Armstrong PW.

Circulation. 2008 Sep 23;118(13):1335-46. doi: 10.1161/CIRCULATIONAHA.108.767772. Epub 2008 Sep 8.

2.

Contribution of angiographic and electrocardiographic parameters of reperfusion to prediction of mortality and morbidity after acute ST-elevation myocardial infarction: Insights from the Assessment of Pexelizumab in Acute Myocardial Infarction trial.

Brener SJ, Westerhout CM, Fu Y, Todaro TG, Moliterno DJ, Wagner GS, Granger CB, Armstrong PW; APEX-AMI Investigators.

Am Heart J. 2009 Nov;158(5):755-60. doi: 10.1016/j.ahj.2009.09.009. Epub 2009 Oct 3.

PMID:
19853693
3.

Influence of ST-segment recovery on infarct size and ejection fraction in patients with ST-segment elevation myocardial infarction receiving primary percutaneous coronary intervention.

Hallén J, Sejersten M, Johanson P, Atar D, Clemmensen PM.

Am J Cardiol. 2010 May 1;105(9):1223-8. doi: 10.1016/j.amjcard.2009.12.034. Epub 2010 Mar 11.

PMID:
20403470
4.
5.

Usefulness of the QRS score as a strong prognostic marker in patients discharged after undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction.

Tjandrawidjaja MC, Fu Y, Westerhout CM, Wagner GS, Granger CB, Armstrong PW; APEX-AMI Investigators.

Am J Cardiol. 2010 Sep 1;106(5):630-4. doi: 10.1016/j.amjcard.2010.04.013.

PMID:
20723636
6.

Prognostic utility of comparative methods for assessment of ST-segment resolution after primary angioplasty for acute myocardial infarction: the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) trial.

McLaughlin MG, Stone GW, Aymong E, Gardner G, Mehran R, Lansky AJ, Grines CL, Tcheng JE, Cox DA, Stuckey T, Garcia E, Guagliumi G, Turco M, Josephson ME, Zimetbaum P; Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications trial.

J Am Coll Cardiol. 2004 Sep 15;44(6):1215-23.

7.

Comparison of prognostic value of epicardial blood flow and early ST-segment resolution after primary coronary angioplasty. ANIN--Myocardial Infarction Registry.

Kalińczuk Ł, Przyłuski J, Karcz M, Petryka J, Kaczmarska E, Bekta P, Kepka C, Kruk M, Pregowski J, Kadziela J, Deptuch T, Skwarek M, Cedro K, Ciszewski M, Debski A, Ciszewski A, Chmielak Z, Demkow M, Witkowski A, Ruzyłło W.

Kardiol Pol. 2007 Jan;65(1):1-10; discussion 11-2. English, Polish.

9.

Comparison of different methods of ST segment resolution analysis for prediction of 1-year mortality after primary angioplasty for acute myocardial infarction.

Przyluski J, Karcz M, Kalińczuk L, Kruk M, Pregowski J, Kaczmarska E, Petryka J, Bekta P, Deptuch T, Kepka C, Witkowski A, Ruzyllo W; ANIN Myocardial Infarction Registry.

Ann Noninvasive Electrocardiol. 2007 Jan;12(1):5-14.

PMID:
17286645
10.

Significance of T-wave amplitude and dynamics at the time of reperfusion in patients with acute ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention.

Sørensen JT, Murinson MA, Kaltoft AK, Nikus KC, Wagner GS, Terkelsen CJ.

J Electrocardiol. 2009 Nov-Dec;42(6):677-83. doi: 10.1016/j.jelectrocard.2009.06.003.

PMID:
19595361
11.

Prognostic impact of contrast-enhanced CMR early after acute ST segment elevation myocardial infarction (STEMI) in a regional STEMI network: results of the "Herzinfarktverbund Essen".

Bruder O, Breuckmann F, Jensen C, Jochims M, Naber CK, Barkhausen J, Erbel R, Sabin GV; Herzinfarktverbund Essen.

Herz. 2008 Mar;33(2):136-42. doi: 10.1007/s00059-008-3102-8.

PMID:
18344033
12.
13.

ST-segment elevation during dobutamine stress testing predicts functional recovery after acute myocardial infarction.

Piérard LA, Lancellotti P, Kulbertus HE.

Am Heart J. 1999 Mar;137(3):500-11.

PMID:
10047633
14.

Usefulness of peak troponin-T to predict infarct size and long-term outcome in patients with first acute myocardial infarction after primary percutaneous coronary intervention.

Hassan AK, Bergheanu SC, Hasan-Ali H, Liem SS, van der Laarse A, Wolterbeek R, Atsma DE, Schalij MJ, Jukema JW.

Am J Cardiol. 2009 Mar 15;103(6):779-84. doi: 10.1016/j.amjcard.2008.11.031. Epub 2009 Jan 24.

PMID:
19268731
15.

Comparison of myocardial reperfusion in patients undergoing percutaneous coronary intervention in ST-segment elevation acute myocardial infarction with versus without diabetes mellitus (from the EMERALD Trial).

Marso SP, Miller T, Rutherford BD, Gibbons RJ, Qureshi M, Kalynych A, Turco M, Schultheiss HP, Mehran R, Krucoff MW, Lansky AJ, Stone GW.

Am J Cardiol. 2007 Jul 15;100(2):206-10. Epub 2007 Jun 4.

PMID:
17631071
16.

ST-segment deviation on the admission electrocardiogram, treatment strategy, and outcome in non-ST-elevation acute coronary syndromes A substudy of the Invasive versus Conservative Treatment in Unstable coronary Syndromes (ICTUS) Trial.

Windhausen F, Hirsch A, Tijssen JG, Cornel JH, Verheugt FW, Klees MI, de Winter RJ; Invasive versus Conservative Treatment in Unstable coronary Syndromes (ICTUS) investigators.

J Electrocardiol. 2007 Sep-Oct;40(5):408-15. Epub 2007 Jul 2.

PMID:
17604045
17.

Comparison of the usefulness of N-terminal pro-brain natriuretic peptide to other serum biomarkers as an early predictor of ST-segment recovery after primary percutaneous coronary intervention.

Verouden NJ, Haeck JD, Kuijt WJ, van Geloven N, Koch KT, Henriques JP, Baan J, Vis MM, van Straalen JP, Fischer J, Piek JJ, Tijssen JG, de Winter RJ.

Am J Cardiol. 2010 Apr 15;105(8):1047-52. doi: 10.1016/j.amjcard.2009.12.002. Epub 2010 Feb 20.

PMID:
20381651
18.

Level of Selvester QRS score is predictive of ST-segment resolution and 30-day outcomes in patients with acute myocardial infarction undergoing primary coronary intervention.

Uyarel H, Cam N, Okmen E, Kasikcioglu H, Tartan Z, Akgul O, Simsek D, Cetin M, Bozbeyoglu E, Buturak A, Uzunlar B.

Am Heart J. 2006 Jun;151(6):1239.e1-7.

PMID:
16781226
19.

Prognostic significance of admission cardiac troponin T in patients treated successfully with direct percutaneous interventions for acute ST-segment elevation myocardial infarction.

Kurowski V, Hartmann F, Killermann DP, Giannitsis E, Wiegand UK, Frey N, Müller-Bardorff M, Richardt G, Katus HA.

Crit Care Med. 2002 Oct;30(10):2229-35.

PMID:
12394949
20.

Clinical benefits of adjunctive tirofiban therapy in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.

Shen J, Zhang Q, Zhang RY, Zhang JS, Hu J, Yang ZK, Zheng AF, Zhang X, Shen WF.

Coron Artery Dis. 2008 Jun;19(4):271-7. doi: 10.1097/MCA.0b013e3282f487e0.

PMID:
18480672

Supplemental Content

Support Center